Articles tagged with Dopaminergic Neurons
Researchers at Rockefeller University discover how dopamine alters connections between neurons in fly brain to change odor responses. This study parallels the action of dopamine in human brain, suggesting a coordinated mechanism for flexible behavior.
Researchers at the University at Buffalo have developed a method to convert skin cells into functional dopamine neurons by manipulating the expression of p53 and Tet1 enzymes. This breakthrough enables the efficient generation of patient-specific neurons that can be transplanted into the brain to repair faulty dopamine neurons.
Researchers at Cold Spring Harbor Laboratory have observed direct evidence of synaptic plasticity in the fruit fly brain while flies learn. The team found a dramatic reduction in synaptic strength upon subsequent presentations of the test odor, indicating a decrease in its attractiveness.
Researchers mapped brain circuits that cause hyperactive dopamine release in response to cocaine. The study found a key relay between the extended amygdala and ventral subiculum drives persistent dopamine hyperactivity.
Scientists from Scripps Research Institute have found that the interaction between a pair of brain proteins has a substantial effect on memory formation. The study reveals that when these two receptors interact, the ghrelin receptor changes the structure of the dopamine receptor and alters its signaling pathway.
Scientists at NCBS identify new roles for calcium refill mechanisms in regulating dopamine levels in the brain. Inhibiting these mechanisms disrupts dopamine synthesis and transport, affecting gene expression.
Research reveals dopamine transmission via D1 receptors is essential for information flow through the basal ganglia to control movements. Lack of D1 receptor-mediated dopamine transmission disrupts 'direct pathway' and results in slowness of movements in Parkinson's disease.
Researchers at Columbia University Irving Medical Center discovered that long-term use of L-DOPA leads to dyskinesia due to striatonigral neurons becoming less responsive to GABA. This suggests that modulating these neurons could prevent or delay dyskinesia.
Researchers found that external brain stimulation, specifically transcranial direct current stimulation (tDCS), can compensate for the loss of dopamine in people with Parkinson's disease by decreasing the effort the brain has to put into getting its motor neurons to fire. This correction improves some patients' motor symptoms.
A study published in the Journal of Neuroscience by Texas A&M Health Science Center researchers found that a specific type of brain cell plays a crucial role in addiction. The findings suggest that periodic consumption of alcohol alters the structure and function of these cells, leading to increased cravings and cycle of alcoholism.
Brain cells in Parkinson's disease are vulnerable due to high energy consumption, which can lead to exhaustion and cell death. This discovery may lead to new treatment strategies for reducing energy consumption or improving energy production in neurons.
Researchers at Rockefeller University have identified two proteins, SATB1 and ZDHHC2, that appear to protect neurons from degeneration in Parkinson's disease. These proteins were found to be more abundant in dopamine-producing neurons in the substantia nigra pars compacta region, which is less affected by the disease.
Researchers discovered that a small population of neurons in the brain's reward centre can respond with both yes and no, regulating reward behaviour. Shutting down one language increases mice's predilection for cocaine, while humans with mutation of a key gene are 10 times more vulnerable to severe addiction
Researchers at the University of Pittsburgh School of Medicine have developed a gene therapy that reduces production of brain protein α-synuclein, preventing Parkinson's disease progression in an animal study. The therapy targets mitochondria and α-synuclein interaction, showing promising results in protecting dopamine neurons.
Dopamine-producing neurons play a crucial role in signal transmission, influencing motor control, reward behaviour, motivation, and impulse control. The discovery reveals that glutamate facilitates rapid signal transmission, enabling the brain to respond quickly to stimuli.
Researchers at the Buck Institute have confirmed that Parkinson's disease mutations alter mitochondrial function in human cells for the first time. The study provides a tool for testing potential therapeutics and promises to address concerns about genetic differences between patients.
New research confirms GDNF is not necessary for maintaining dopamine neurons, contradicting previous findings. The absence of GDNF in mice did not cause significant damage to the midbrain dopamine system or trigger motor disorders.
Researchers found altered patterns and frequencies of electrical activity in dopamine midbrain neurons critical for emotional and cognitive processing. These findings suggest that impaired dopamine neuronal activity contributes to schizophrenia's negative symptoms, such as cognitive deficits and impaired motivation.
Researchers from the University of Leicester used electrophysiology to capture electrical signals from dopamine neurons in the forebrain, revealing that these cells are active when fish swim. The study suggests that dopamine plays a key role in regulating excitability of spinal networks and may contribute to motor side effects of dopam...
Researchers at IRCM have discovered a mechanism that regulates dopamine levels in the brain, which could lead to new treatments for Parkinson's disease. The Rgs6 gene plays a crucial role in preventing excessive dopaminergic signalling and cellular stress.
Transplantation of stem-cell-derived dopamine neurons restores motor function in a rat model of Parkinson's disease, suggesting a viable alternative to existing treatments. The therapy demonstrates efficacy and potency similar to fetal neurons, paving the way for human clinical trials.
Scientists at TSRI found that brief workouts can reduce the risk of relapse in rats withdrawing from methamphetamine. Exercise affected a brain region previously unassociated with meth withdrawal, suggesting new avenues for therapy.
Researchers found that neurons from schizophrenia patients secrete higher amounts of dopamine, norepinephrine, and epinephrine. This discovery offers a new insight into the chemical basis of schizophrenia, potentially leading to new drug targets and therapies.
Researchers at Emory University School of Medicine found that XPro1595 can protect vulnerable neurons and reduce motor deficits in a rat model of Parkinson's disease. The drug targets tumor necrosis factor, a critical inflammatory signaling molecule, and showed benefits when administered by subcutaneous injection.
Research suggests that impaired inhibition of medium spiny neurons in the nucleus accumbens contributes to childhood depression. The study found that nomifensine can alleviate depressive behaviors by reducing neuron membrane excitability.
Researchers found that Zhichan decoction increased dihydroxyphenylacetic acid levels up to 10-fold after neural stem cell transplantation, promoting the differentiation of dopaminergic neurons. This study suggests a potential treatment for Parkinson's disease using traditional Chinese medicine.
Knocking down α-synuclein in a methamphetamine-induced model of Parkinson's disease reduced depression manifestations, increased striatal dopamine and tyrosine hydroxylase levels, and decreased reactive oxygen species. This suggests that α-synuclein may exacerbate oxidative stress and apoptosis in dopaminergic neurons.
Transplanted dopamine neurons from fetal tissue remain healthy for at least 14 years after transplantation, according to a recent study. The findings suggest that stem cells can be a viable source for transplant-ready dopamine neurons, providing further rationale for pursuing this therapeutic approach.
Researchers at Mayo Clinic and Aarhus University have discovered a receptor system critical for correct wiring of the dopaminergic brain area during embryonic development. The study found that a cut in the SorCS2 receptor can induce cell death after peripheral nervous system damage, leading to hyperactivity and attention deficits in mice.
Researchers at Georgia Institute of Technology and Emory University discovered that altered blood flow induces epigenetic alterations in endothelial cells, leading to atherosclerosis. Additionally, they found that reduced expression of the aldehyde dehydrogenase 1 enzyme makes dopaminergic neurons more susceptible to degeneration in Pa...
Research by Stan Floresco reveals the dynamic competition between brain regions to inform decisions. The frontal lobes temper impulses towards larger, uncertain rewards, while dopamine neurons provide short-term updates on recent outcomes.
A study by neuroscientists at the University of Pennsylvania found that stimulation of dopamine-containing neurons can modify human learning. When participants received a reward, they tended to repeat the button press that resulted in the reward, even when it was no longer associated with the action.
Researchers at Plymouth University will use drug and gene therapies to test whether altering mitochondrial fission or fusion improves dopamine-producing nerve cells in experimental models of Parkinson's Disease. The goal is to identify a potential new therapeutic strategy for this brain disorder, potentially slowing disease progress an...
Researchers found that boosting runaway neuronal activity triggers a compensatory self-stabilizing response, restoring balance and reversing depression-like behaviors. This 'homeostatic resilience' mechanism may lead to new antidepressant strategies, targeting the brain's reward circuit.
Researchers found that activating neurons instead of dampening them opens a new avenue to mimic and promote natural resilience. The study suggests a conceptually novel therapeutic strategy for treating depression.
A study published in Cell identifies a biological process that triggers a particular form of Parkinson's disease, leading to degeneration of dopamine-producing nerve cells. The research, led by Johns Hopkins Medicine, has shed light on the origins of Parkinson's disease and may lead to new treatments.
ProSavin, a novel gene therapy, has shown promise in reducing motor symptoms of Parkinson's disease by delivering dopamine-making genes directly into the brain. Significant improvements in motor scores were seen in all patients after treatment.
Researchers at the University at Buffalo used optogenetics to stimulate dopamine neurons, reducing binge drinking behavior in rats. The technique has potential applications for treating alcoholism, mental illnesses, and neurological diseases.
Scientists have discovered that microRNA-128 plays a crucial role in regulating gene expression in neurons, leading to increased neuron activity and epilepsy. The study used mice experiments to demonstrate the effects of reducing microRNA-128 levels, which can help hamper muscle activation.
Recent study published in Neural Regeneration Research shows that Chinese medicines used for tonifying the kidney can protect nerve cells by regulating apoptosis-related factors and neurotrophic factors. Herba Epimedii and Herba Cistanches were found to be effective in inhibiting dopaminergic neuron apoptosis.
Researchers used patient-derived stem cells to show that a genetic mutation in the alpha-synuclein gene increases vulnerability to pesticides, leading to Parkinson's disease. The study identified a molecule that protects neurons from pesticide damage and may have potential clinical implications for treating the disease.
Researchers have found that dopamine neurons are sensitive to reward but not punishment, suggesting a separate dimension for aversiveness. This discovery implies the existence of four neurotransmitters representing two dimensions of value.
A novel gene therapy approach using nanoparticles to deliver GDNF may halt Parkinson's disease progression and reverse symptoms. This non-invasive method bypasses the blood-brain barrier, enabling continuous production of GDNF in brain cells.
Researchers found movement deficits and loss of tyrosine-hydroxylase-positive fibers in the striatum, with no significant decrease in nigral dopaminergic neurons. The study suggests that gliosis in the substantia nigra plays a role in introducing dopaminergic deficits.
A new study from the Scripps Research Institute found that a complex set of overlapping neuronal circuits in fruit flies drives temperature preferences. The research used imaging techniques to visualize neuron activity and showed that dopaminergic neurons process multiple inputs to generate outputs, influencing behavior.
Researchers found that benomyl exposure can trigger a cascade of cellular events leading to Parkinson's disease, even in individuals without prior pesticide exposure. The study suggests developing new drugs to protect ALDH activity may slow disease progression.
Researchers at Karolinska Institutet have identified two molecules that stimulate liver X receptors in the midbrain, promoting the production of new dopamine-producing neurons. These findings may lead to the development of regenerative medicine treatments for Parkinson's disease.
New research sheds light on the complexities of learning problems in neurofibromatosis 1 patients. The study found that both increased RAS function and reduced dopamine levels contribute to cognitive dysfunction in individuals with NF1. Developing personalized therapies is now a priority.
Scientists have discovered that a specific region of the brain, the ventral tegmental area, plays a key role in both inducing and relieving depression-like symptoms. By controlling this region with light stimulation, researchers were able to reverse depressed states in mice, providing new hope for future treatments.
Researchers developed a way to derive dopaminergic neurons from adult bone marrow stem cells in monkeys. The new neurons were then transplanted into the same monkeys with induced Parkinson's disease, showing significant improvement in motor function.
Researchers have discovered that lithium restores cognitive function in Down syndrome mice, while stem cell-derived dopaminergic neurons improve motor defects in Parkinson's disease monkeys. Additionally, inhibiting a key protein in Alzheimer's disease may reduce plaque formation and improve memory tasks. Moreover, tempering inflammati...
Researchers found that GM1 ganglioside improved symptoms and slowed disease progression in patients with Parkinson's disease over a 2.5-year period. The study enrolled 77 subjects and followed them for 120 weeks, with significant benefits observed when participants stopped taking the drug.
A Scripps Research Institute team has identified a key factor controlling damage to brain cells in a mouse model of Parkinson's disease. The discovery, led by scientist Bruno Conti, points to the IL-13 receptor as a potential target for new treatment options.
Researchers at the University of Pennsylvania School of Medicine have found that injecting synthetic, misfolded α-Syn protein into healthy mice recapitulates Parkinson's disease progression, leading to dopamine neuron death and Lewy body formation. The study establishes a mechanistic link between α-Syn transmission and neurodegeneration.
Researchers found dopamine neurons release GABA, a neurotransmitter that lowers neuronal activity, which could explain why restoring only dopamine leads to waning improvements in Parkinson's patients. This discovery highlights the complex interplay between dopamine and GABA in brain disorders like depression and addiction.
Researchers have created a new family of compounds that could slow Parkinson's disease progression by shutting down the Cav1.3 channel, which allows calcium to flood into dopamine neurons. The compounds were developed by Northwestern University scientists and show promise in animal trials without obvious side effects.
Scientists at UH Center for Nuclear Receptors and Cell Signaling discovered LXRbeta, a nuclear receptor that promotes the survival of dopaminergic neurons, which are the main source of dopamine in the central nervous system. The presence of LXRbeta may offer protection against neurodegeneration of the midbrain.
Scientists from the Max Planck Institute identified four different types of dopamine-releasing nerve cells involved in forming positive and negative memories in fruit flies. These nerve cells use dopamine to communicate with other neurons, and their activation can signal aversive or rewarding stimuli.
Embryonic stem cells can be used to replace dopamine-producing cells in Parkinson's disease patients with high efficiency. Researchers have identified specific genes associated with each stage of neuronal differentiation, allowing for more precise cell purification strategies.
Scientists at Harvard University have created a comprehensive list of inputs that connect directly to dopamine neurons in the brain, revealing new connections and insights into Parkinson's disease and addiction. The study uses genetically-modified rabies virus to track neural pathways, providing quantitative data for future investigati...